Overview
Independent HVAC/R service provider with nationwide coverage and support.
Founded
1992
Deals · 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Electra Therapeutics | Oct 2025Led | $183 MSeries C | |
Be Biopharma | Jan 2025Participated | $92 MSeries C | |
Alumis | Mar 2024Participated | $259 MSeries C | |
Synnovation Therapeutics | Jan 2024Participated | $102 MSeries A | |
Isotopen Technologien München | Jun 2023Participated | $273 MOther Equity | |
CARGO Therapeutics | Mar 2023Participated | $200 MSeries A | |
Hexagon Bio | Feb 2023Participated | $77 MSeries B | |
IconOVir Bio | Jan 2021Led | $77 MSeries A | |
C4 Therapeutics | Jun 2020Participated | $170 MSeries B | |
EQRx | Jan 2020Led | $200 MSeries A | |
Kronos Bio | Jul 2019Participated | $105 MSeries A | |
Electra Therapeutics | Oct 2025Led | $183 MSeries C | |
Be Biopharma | Jan 2025Participated | $92 MSeries C | |
Alumis | Mar 2024Participated | $259 MSeries C | |
Synnovation Therapeutics | Jan 2024Participated | $102 MSeries A | |
Isotopen Technologien München | Jun 2023Participated | $273 MOther Equity | |
CARGO Therapeutics | Mar 2023Participated | $200 MSeries A | |
Hexagon Bio | Feb 2023Participated | $77 MSeries B | |
IconOVir Bio | Jan 2021Led | $77 MSeries A | |
C4 Therapeutics | Jun 2020Participated | $170 MSeries B | |
EQRx | Jan 2020Led | $200 MSeries A | |
Kronos Bio | Jul 2019Participated | $105 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 2 | 3 |
| Series B | 0 | 2 |
| Series C+ | 1 | 2 |
| Other Equity | 0 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Jul '19 | 1 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 1 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 1 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 1 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 1 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 11 |
| Space & Frontier Tech | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 0 |
| $10M-$25M | 0 |
| $25M-$50M | 0 |
| $50M-$100M | 3 |
| $100M-$250M | 6 |
| $250M-$500M | 2 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 10 |
| Europe | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Cormorant Asset Management | 3 |
| Google Ventures | 3 |
| HBM Healthcare Investments | 3 |
| Ally Bridge Group | 2 |
| ARCH Venture Partners | 2 |
| Janus Henderson Investors | 2 |
| Lilly Asia Ventures | 2 |
| Logos Capital | 2 |
| Omega Funds | 2 |
| Perceptive Advisors | 2 |
| Piper Heartland Healthcare Capital | 2 |
| Polaris Partners | 2 |
| RA Capital Management | 2 |
| RTW Investments | 2 |
| Samsara BioCapital | 2 |
| T. Rowe Price Associates | 2 |
| Third Rock Ventures | 2 |
| Vida Ventures | 2 |
| 3E Bioventures Capital | 1 |
| 8VC | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 27% |
| Participating | 8 | 73% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 3 | 100% |